Glucocorticoid receptor (GR) activation induces apoptosis of granule cells in the hippocampus. In contrast, neuroprotection is seen after mineralocorticoid receptor (MR) activation. To date there is no in vivo evidence for direct interactions between corticosteroids and any of the key regulatory molecules of programmed cell death. In this report, we show that the opposing actions of MR and GR on neuronal survival result from their ability to differentially influence the expression of members of the bcl-2 gene family; specifically, in the rat hippocampus, activation of GR induces cell death by increasing the ratio of the proapoptotic molecule Bax relative to the antiapoptotic molecules Bcl-2 or Bcl-x L ; the opposite effect is observed after stimulation of MR. The same results were obtained in both young and aged animals; however, older subjects (which were more susceptible to GRmediated apoptosis) tended to express the antiapoptotic genes more robustly. Using a loss-of-function mouse model, we corroborated the observations made in the rat, demonstrating Bax to be essential in the GR-mediated cell death-signaling cascade. In addition, we show that GR activation increases and MR activation decreases levels of the tumor suppressor protein p53 (a direct transcriptional regulator of bax and bcl-2 genes), thus providing new information on the early genetic events linking corticosteroid receptors with apoptosis in the nervous system. 
The hippocampus is highly sensitive to corticosteroids (CS), exemplified by its enriched complement of CS receptors and its pivotal role in hypothalamic-pituitaryadrenal axis feedback regulatory mechanisms (1) . Two types of CS receptor are found in the brain: mineralocorticoid (MR) and glucocorticoid (GR) receptors. In the rat, these receptors share a common endogenous ligand corticosterone (CORT); selective MR or GR activation is apparently conferred by the ϳ10-fold greater affinity of MR for CORT (1) . Differential activation of this dual receptor system may account for the opposing actions of corticosteroids on neuronal proliferation, survival, and death in one hippocampal subfield, the dentate gyrus (2-4). The dentate gyrus displays both MR and GR (5) , and there is evidence showing that GR occupation as occurs during stress, for example, leads to an arrest of neurogenesis in the dentate gyrus (6) ; at the same time, GR occupation stimulates apoptosis within the granular and hilar cell populations of the dentate gyrus (3) . On the other hand, MR activation is essential for maintenance of the granule cell layer (7) (8) (9) , and in a previous study we demonstrated that MR activation can protect dentate gyrus neurons against acute GR ligand-mediated apoptosis (3) . In the latter study, we also observed that aged rats are more vulnerable to GR-induced cell death, a finding attributed to age-associated declines in basal CORT secretion and changes in the availability of MR and GR (5) .
The regulation of apoptosis is complex, but it is now established that proteins encoded by the bcl-2 gene family are major regulatory components of the apoptotic pathway (10, 11) . The Bcl-2 family comprises death inducer (e.g., Bax, Bcl-x S ) and death repressor (e.g., Bcl-2, Bcl-x L ) proteins, several of which can form homo-and heterodimers (10 -12) . These proteins are activated by physiological or injurious stimuli and appear to operate upstream of events leading to the final execution phase of the apoptotic process, which involves the activation of cysteine proteases-the caspases (13) (14) (15) . Whereas the susceptibility of an individual cell to apoptosistriggering stimuli is largely determined by its genetic content, metabolic state, and developmental/proliferative state, as well as its distinct receptor and signal transduction pathways (15) (16) (17) , the ratio of death inducer to death repressor proteins seems to exert a rheostat-like control over whether an individual cell will ultimately survive or die (18) .
bcl-2 expression in the brain declines rapidly after birth, but areas that display postnatal neurogenesis (e.g., the dentate gyrus; see refs 19 -21) continue to express bcl-2 for an extended period of time (11, 22) ; in addition, bcl-2 expression can be induced in the adult brain, including the hippocampus (23) (24) (25) . Unlike bcl-2, the expression of another member of this family, bcl-x L , occurs in the brain throughout embryonic and postnatal life (25) (26) (27) (28) (29) . The large antiapoptotic splice variant of bcl-x (bcl-x L ) appears to be located exclusively in neurons (11) ; bcl-x L has been localized in both pyramidal and granular neurons of the hippocampus (27, 28) . In contrast, levels of the smaller proapoptotic bcl-x splice variant, bcl-x S , are only barely detectable in mature brain (26, 27) . Given that bcl-x expression does not display the spatial and temporal constraints associated with the expression of bcl-2, it has been suggested that Bcl-x L may gradually substitute for Bcl-2 during development (27) . This molecule has also been suggested to be critical for the survival of postnatal neurons (26, 28, 30) . The proapoptotic protein Bax (31-32) is widely distributed in the brain, its spatial distribution in the hippocampus (dentate gyrus and CA2 areas Ͼ CA3 and CA1 areas) corresponding closely to that of MR (see ref 5) . A reciprocal distribution pattern of Bax and Bcl-2 is frequently seen among cell populations that are the targets of apoptotic stimuli (24, 29, 33, 34) .
To date, none of the Bcl-2 family of proteins have been shown to be directly regulated by CS. Evidence from other studies, however, suggests that the link between CS and Bcl-2-related molecules may be provided by the tumor suppressor protein p53, which shows a ubiquitous distribution and whose trans-activation potential can be modulated by GR (35) . Furthermore, there is evidence that p53 can, respectively, induce and repress bax and bcl-2 transcription (36, 37) . This work represents the first attempt to define some of the molecular signaling pathways underlying the differential effects of corticosteroids on neuronal survival (MR activation) and apoptosis (GR activation) in vivo. Studies were performed in both young and aged rats in light of previous work showing the greater vulnerability of hippocampal neurons to glucocorticoid treatment in aged animals (3, 4).
MATERIALS AND METHODS

Animals
Male Wistar rats, aged 3 and 24 months and housed under standard laboratory conditions, were given one of three treatments over a period of 8 days: saline (control); corticosterone (Sigma Chemicals, St. Louis, Mo.; 1 mg/kg; initially dissolved in 0.001% ethanol and finally in saline; CORT); or dexamethasone (Fortecortin; 100 g/kg; Merck; Darmstadt, Germany; DEX). MR selectivity of the dose of CORT used has been reported previously (38; see also ref 3). Saline, CORT, and DEX were administered i.p. in two divided daily doses. In some studies, wild-type (wt) and bax knockout (bax Ϫ/Ϫ) mice (see below), aged 20 -24 months, were used for testing the apoptotic effects of DEX (100 g/kg). All the in vivo procedures conformed to local animal welfare legislation. Animals were killed between 13:00 and 14:00, at which time their brains were immediately removed, frozen in cooled isopentane, and stored at Ϫ80°C before cryosectioning (10 m). Tissue sections (mounted on coded slides) were processed using in situ nick end labeling (TUNEL) histochemistry, in situ hybridization histochemistry, or reverse transcriptase-polymerase chain reaction (RT-PCR) as described below. For the histochemical analyses, six anatomically matched cryosections, each separated by 50 m (to circumvent the need for correction of counting error during quantification), were taken from the dorsal hippocampus (between bregma -3.3 and -4.3; ref 39) .
The mouse bax gene consists of six exons assembled into multiple, alternatively spliced transcripts encoding a 21 kDa membrane (␣) and two forms of cytosolic protein (␤ and ␥) (31) . To generate mice lacking all isoforms, we targeted the first four exons, which encompass most of the protein coding sequence. The bacterial lacZ gene, under the transcriptional regulatory sequences of the bax gene, was inserted into the construct to serve as a genetic marker of the mutation (Fig. 1) .
Construction of the targeting replacement vector and generation of bax knockout mice
Genomic clones spanning the entire mouse bax gene were isolated by screening of a FIX mouse genomic library (strain 129/SV DNA; Stratagene, Heidelberg, Germany) with a 311 bp mouse bax cDNA corresponding to nucleotides 49 to 360 of the rat bax cDNA sequence (31) . The clones were characterized in detail by standard molecular biology techniques. Initially, a 5.2 kb HindIII-HindIII DNA fragment containing the last two exons as well as sufficient flanking sequences to achieve a good targeting efficiency was subcloned into pGNA plasmid (ref 40 ; pGNA plasmid kindly provided by Dr. P. Brûlet). The targeting vector was generated by the subsequent cloning of an AseI ϫ BglI DNA fragment comprising ϳ2 kb of 5Ј-flanking sequences of the gene (BglI cuts 40 bp upstream of the AUG translation initiation codon). The replacement vector finally contained 7.5 kilobases of homologous bax genomic DNA, in which the first four exons of the gene (contained in the BglI-HindIII DNA region) were removed and replaced by the lacZ. To achieve an enrichment of the homologous recombination events, we used a modified version (41) of the positive-negative selection procedure (42) to introduce the negative selection cassette (the HSV thymidine kinase gene under the promoter of the phosphoglycer-ate kinase gene) at the ends of the targeting vector after its linearization with NotI.
Procedures for electroporation and selection of R1 ES cells (generously provided by Dr. A. Nagy, Department of Genetics, University of Toronto, Toronto, Canada; 43) have been described (44) . For the identification of homologous recombinant cell clones, genomic DNA from individual doubledrug resistant ES clones was double digested with the restriction enzymes EcoRI and EcoRV and subjected to Southern blot analysis. As an external probe, we used a 152 bp Sal I-AseI fragment, which distinguishes a 9.2 kb band originating from the wild-type allele, and a 5 kb band that derives from the disrupted allele (Fig. 1) . The recombinant clones were further analyzed in Southern blots using 3Ј external and internal probes. Four of the 280 clones were found to carry the desired allele. Homologous recombinant ES cells were injected into 3.5-day-old C57BL/6 blastocysts that were subsequently implanted into pseudopregnant recipients. The resulting male chimeras were mated to C57BL/6 females, and germline transmission of the mutant allele was identified by Southern blot analysis of tail DNA from F1 offspring. Western blot analysis was used to confirm the absence of bax expression in the baxϪ/Ϫ mice (see Fig. 7 ).
Histochemistry
TUNEL was used to detect cells undergoing apoptosis (45) ; Giemsa-counterstained sections were then microscopically examined according to previously described morphological criteria (3) . TUNEL-stained cells and unlabeled healthy cells in the pyramidal blades (granule cell layer) of the dentate gyrus were counted. Five readings were obtained for each parameter from anatomically matched sections from each animal (nϭ4). An 'apoptotic index' was derived from the number of apoptotic cells occurring per 10,000 healthy cells (3) . To complement the RT-PCR measurements of bcl-2, bcl-x, and bax mRNA, in situ hybridization histochemistry was also performed on a sample of sections from each treatment: 35 S-dATP-labeled 48-mer antisense oligonucleotide probes complementary to bases 27-66 of bcl-2, 141-180 of bcl-x L , and 15-54 of bax were used (46) .
Detection of bcl-2, bcl-x L , and bax mRNA
Relative levels of bcl-2, bcl-x L , and bax mRNA were measured in hippocampal tissue using a semiquantitative RT-PCR method. Total RNA, free from chromosomal DNA contamination, was isolated and reverse transcribed with SUPERSCRIPT II RNase H-Reverse transcriptase (Life Technologies, Inc., Eggenstein, Germany) using custom-synthesized (Life Technologies) oligo-dT [12] [13] [14] [15] [16] [17] [18] primers for bcl-x L and bax PCR, and a sequencespecific antisense primer corresponding to nucleotides 638 -657 of the cDNA sequence for bcl-2 PCR (Table 1) of each dNTP, two units of AmpliTaq DNA Polymerase (Perkin Elmer, Ü berlingen, Germany), and 1ϫ GeneAmp buffer (Perkin Elmer). The reaction mixture was overlayered with mineral oil and PCR amplification was conducted in a Perkin-Elmer thermocycler for 21 cycles (bcl-x L ), 22 cycles (bax), 26 cycles (bcl-2), or 17 cycles (G3PDH) using the following conditions: denaturation 40 s 94°C; annealing 40 s 53°C (bcl-x L ), 55°C (bcl-2), or 56°C (bax and G3PDH); primer extension 2 min. 72°C. PCR products were electrophoresed on agarose gels and visualized under UV light using SYBR Green DNA stain (Biozym, Hessisch Oldendorf, Germany). Relative differences in the amount of amplified PCR products between treatment groups were assessed semiquantitatively by radioactive ( 32 P) dot blot hybridizations with gene-specific antisense cDNA probes. Blot intensities (arbitrary optical density units) were measured using a Bio-Imaging Analyzer system (Fuji) combined with densitometry. Intensities for amplified bax, bcl-x L , and bcl-2 were normalized against those obtained for G3PDH in the same sample. The linearity of PCR amplification was verified by amplifying serial dilutions of reverse transcribed cDNA.
Western blot assays
Frozen hippocampi were processed according to the previously described procedures (47) , and equal amounts of protein were subjected to gel electrophoresis and electrophoretically transferred onto PVDF membranes (Amersham, Braunschweig, Germany). Blots were washed with Tris-buffered saline, treated with 2% (v/v) H 2 O 2 in 20% methanol/ 0.1 M Tris (pH 7.5) for 30 min, and then preblocked (3 h) in TBST buffer (50 mM Tris, pH 7.5; 190 mM NaCl; 0.1% Tween 20) containing 8% (w/v) dried nonfat milk (Bio-Rad, Munich, Germany), and 1% normal donkey serum. The preblock solution was removed and replaced with fresh solution containing 0.025-0.1% (v/v) of either an anti-Bax, anti-Bclx L , or anti-Bcl-2 antiserum (PharMingen, Hamburg, Germany) or a pan-p53 antibody (Oncogene Research, Cambridge, Mass.). After overnight incubation at 4°C, blots were washed in TBST buffer before incubation (1 h, room temperature) with 0.1 g/ml of horseradish peroxidase-labeled donkey anti-rabbit IgG (Amersham) in TBST containing 5% milk and 0.5% normal rat serum. After washing with TBST, specific protein bands were detected using a chemiluminescent detection system (ECL-Plus, Amersham).
Data analysis
Statistical analysis was carried out using the computed values for each individual animal. Data were scrutinized by one-way analysis of variance and appropriate post hoc tests; comparisons were made with respect to age-matched controls and treatment paradigm. The level of significance was preset at P Յ 0.05.
RESULTS
Influence of MR vs. GR agonists and age on hippocampal cell survival
Chronic treatment with CORT at a dose sufficient to selectively activate only MR, or with the specific GR agonist DEX resulted in opposite effects on dentate cell survival both in young and aged rats (Fig. 2) ; no effects were observed in any other hippocampal subfield. Specifically, exposure to CORT led to a reduction of TUNEL-positive (apoptotic) cells within the dentate gyrus compared to saline-treated animals (PϽ0.05), whereas treatment with the GR specific a The upper and lower primers of each amplification pair represent the 5Ј-and 3Ј-primers, respectively. The 3Ј-primers are antisense.
b Nucleotides corresponding to the amplified sequences. c Reference from which the primer sequence was derived.
Figure 2.
Comparison of incidence of apoptosis in the dentate gyrus of young (3 months) and old (24 months) rats treated with saline (control), corticosterone (CORT), a preferential mineralocorticoid receptor (MR) agonist, and the glucocorticoid receptor-specific agonist dexamethasone (DEX). Each data point represents the mean (Ϯ se) derived from 4 animals (6 sections per animal). Significant differences (PϽ0.05) from saline-treated equally aged groups are indicated by asterisks; crosses represent significant differences (PϽ0.05) between young and aged animals.
ligand DEX significantly increased the apoptotic index (PϽ0.05). As also shown in Fig. 2 , older animals showed higher basal levels of apoptosis (PϽ0.05); the older animals showed greater vulnerability to the apoptotic effects of GR occupation. In both age groups, DEX-induced apoptosis occurred predominantly within the subgranular zone.
Expression of genes regulating cell death as a function of age and differential CS receptor stimulation
Initially, in situ hybridization histochemistry was performed on selected brain sections from salinetreated control animals in order to monitor the expression patterns of bax, bcl-x L , and bcl-2 mRNA in the adult dentate gyrus. All three genes were found to be expressed in the granular layer of the dentate gyrus. These findings were used as a basis for the remainder of the studies in which changes in the steady-state levels of bax, bcl-x L , and bcl-2 mRNA were determined by semiquantitative RT-PCR analysis.
As shown in Fig. 3 , expression of the cell death promoter gene bax was maintained at a similar level in both young and old saline-treated control rats. In contrast, there was a striking age-related decrease (PϽ0.05) in the expression of the cell death inhibitor gene bcl-2, with older animals showing ϳ50% fewer bcl-2 transcripts than younger animals. The older animals showed a significantly lower number of bcl-x L transcripts than their younger counterparts; the splice-variant bcl-x S proved to be undetectable.
Treatment of young and old rats with a dose of CORT sufficient to preferentially activate MR resulted in a significant (PϽ0.05) lowering of bax gene expression (Fig. 4A) . In contrast, treatment with the GR agonist DEX resulted in a marked increase in the levels of bax mRNA in both young and aged rats (Fig.  4A) . The altered patterns of bax expression after the different hormonal manipulations were matched by changes in Bax protein concentrations: Western blot analysis demonstrated that DEX stimulated, whereas CORT inhibited, Bax levels (Fig. 5) .
Although the relative number of bcl-x L mRNA transcripts were increased (PϽ0.05) in old rats after treatment with the preferential MR agonist CORT, young animals showed no such changes (Fig. 4B) . The changes in the older animals were accompanied by a reduced incidence of apoptosis after CORT treatment (cf. Fig. 2) . In stark contrast, the levels of bcl-x L transcripts were reduced by DEX in young, but not in old, animals (Fig. 4B) . As in the case of the bax gene, age is an important contributory factor to the Age-related differences in the hippocampal expression of bax, bcl-x L , and bcl-2 (steady-state mRNA levels measured by RT-PCR) in rats treated with either CORT (at an MR-selective dose) or DEX (a specific GR agonist). The ages of the animals were 3 months (young) and 24 months (old); means Ϯ se are depicted (nϭ6 -9 per group). Normalized levels of the respective mRNAs found in age-matched control (saline-treated) rats are shown for comparison. Significant differences (PϽ0.05) between young and old rats are indicated by asterisks.
final response (Fig. 4B) . Observations on the bcl-x L mRNA levels were paralleled by changes in the expression of the corresponding protein detected by Western blot analysis (Fig. 5) .
The pattern of bcl-2 expression after the various CS manipulations in young and old rats closely paralleled that observed for bcl-x L expression. Thus, basal levels of bcl-2 gene expression were low in young rats and increased only in the old animals after exposure to CORT (PϽ0.05); both age groups responded to the GR agonist DEX with suppressed expression of the bcl-2 gene (Fig. 4C) . Although Bcl-2 protein could not be measured by Western blotting, a parallelism between changes in bcl-2 expression and cell survival (CORT) or death (DEX) was apparent (cf. Figs. 2, 4C ).
Ratio between expression of pro-and antiapoptotic gene expression as a function of age and CS treatment
As compared to saline-treated age-matched controls, young and old rats treated with the preferential MR agonist CORT exhibited reduced bax:bcl-x L and bax: bcl-2 expression ratios (PϽ0.05; Fig. 6 ), a finding that matches the reduced incidence of apoptosis after this treatment (Fig. 2) . Taking these ratios as a measure, the older animals proved to be slightly more sensitive to CORT than their younger counterparts. Although it was found ( Fig. 2; also see ref 3 ) that younger rats are less sensitive to the apoptosispromoting effects of the GR ligand DEX, we found the younger animals to have an increased bax:bcl-x L expression ratio (PϽ0.05; Fig. 6 ) as compared to the older animals. Further, both age groups showed a similar relative increase (PϽ0.05; Fig. 6 ) in the ratio of bax to bcl-2 gene expression.
Role of Bax in mediating the apoptotic actions of DEX
The mouse bax gene consists of six exons assembled into multiple alternatively spliced transcripts encoding a 21 kDa membrane (␣) and two forms of cytosolic protein (␤ and ␥) (31). To generate mice lacking all isoforms, we targeted the first four exons, which encompass most of the protein coding sequence. The bacterial lacZ gene, under the transcrip- Figure 6 . Effects of saline (control), corticosterone (CORT), or dexamethasone (DEX) on the ratios of (upper panel) bax to bcl-2 and (lower panel) bax to bcl-x L gene expression in the rat hippocampus. The data are shown as mean Ϯ se (nϭ6 -9 per group), calculated on an individual basis. Significant differences (PϽ0.05) between young and old rats are indicated by asterisks; crosses represent significant differences (PϽ0.05) from corresponding age-matched control groups. tional regulatory sequences of the bax gene, was inserted into the construct to serve as a genetic marker of the mutation. The targeting strategy is detailed in Materials and Methods and Fig. 1 .
Wild-type mice treated with the GR agonist DEX showed an abundance of apoptotic cells in the dentate gyrus (Fig. 7a, b) . Whereas the relative number of apoptotic cells by far exceeded that found in rats (cf. Fig. 2) , the spatial distribution of such cells in the two species showed close resemblance. In contrast to the results obtained in wt controls, bax knockout mice (bax Ϫ/Ϫ; Fig. 7c, d) failed to respond to DEX treatment with increased apoptosis of dentate neurons. As shown in Fig. 7e , mice with only partial knockout of bax (bax Ϫ/ϩ) showed an apoptotic response to DEX that was lower than that seen in wt animals. These differences in the occurrence of DEX-induced apoptosis corresponded well with the amounts of Bax protein found by Western blotting (Fig. 7, lower left-hand panel) , indicating a relationship between bax gene dose and incidence and susceptibility to apoptosis.
Age-related differences in CS-mediated changes in p53 expression
Western blot analysis revealed that the tumor suppressor protein p53 is expressed at very low levels in the hippocampus of untreated young rats; treatment with the GR agonist DEX caused a marked increase in p53 (including its phosphorylated forms) protein levels, whereas treatment with MR-activating doses of CORT resulted in an almost complete abolition of p53 expression (Fig. 5) . In contrast, whereas basal p53 expression in aged rats was higher than that in younger animals, levels of this protein failed to respond to treatment with DEX and CORT in a quantitative manner (Fig. 5) .
DISCUSSION
Opposite effects of chronic activation of GR vs. MR on cell survival
The dentate gyrus displays an abundance of MR and GR (5) . We found that the preferential MR agonist, CORT, and the specific GR agonist DEX produced opposite effects on dentate cell survival. Whereas CORT treatment diminished the number of TUNELpositive (apoptotic) cells, treatment with DEX induced a significant degree of apoptosis. These findings are consistent with our earlier unbiased stereological observations that GR, but not MR, activation leads to a reduction in total dentate neuronal numbers (48) . The opposing actions of CORT and DEX on apoptosis applied equally to both young and aged rats. However, the older animals showed appreciably higher basal levels of apoptosis and proved more vulnerable to the apoptotic effects of GR occupation. In both age groups, DEX-induced apoptosis occurred predominantly within the subgranular zone (the area where granule cells are formed before migrating into the granule cell layer; see refs 19, 21, 94) and in the suprapyramidal blade of the granule cell layer.
In general, the above findings are consistent with results from our previous experiments where CORT and DEX were administered on a single occasion (3) . In that study, CORT simply maintained apoptosis at a rate equal to that found in controls. In this context, our present observations are of particular interest since they further indicate that chronic administration of low, MR-activating doses of CORT can reverse cell death occurring under basal conditions. Although we did not identify the specific types of cells that are prevented from entering apoptosis by CORT(e.g., neurons vs. glia), it is likely that they represent neurons, as previous studies have shown that CORT is essential for both granule cell survival and proliferation (7, 9, 50) . Further, the predominant localization of TUNEL-positive cells in the subgranular zone suggests that either newly born granule cells, or their immediate precursors, are the target of GR-mediated apoptosis.
Expression of representative members of the bcl-2 family is influenced by changes in the CS milieu
Influence of age
Our observations on age-related changes in the expression of cell death inhibitor/promoter genes agree with previous reports (25) (26) (27) (28) (29) . Specifically, we found that expression levels of the cell death promoter gene bax were similar in both young and old saline-treated control rats. In contrast, increasing age was associated with a striking decrease in the expression of the cell death inhibitor gene bcl-2; expression of bcl-x L was also significantly lower in old vs. young animals.
Differential control of bax, bcl-x, and bcl-2 expression by MR and GR ligands
Gene targeting experiments have established the importance of Bax for the occurrence of neuronal death (51, 52) ; the death-inducing actions of Bax can be largely antagonized by the presence of Bcl-2 or Bcl-x L (31, 53, 54) . In the present study, a dose of CORT sufficient to preferentially activate MR was found to reduce bax gene expression in the hippocampus of both young and old rats. This finding may be causally related to the ability of CORT to lower the apoptotic index in the dentate gyrus and is consistent with reports that MR agonists promote granule cell survival (7, 9, 50) . In contrast to the results obtained with CORT, treatment with the GR agonist DEX led to a marked increase in the steadystate levels of bax mRNA in both young and aged rats, a result that correlates well with the increased apoptotic index displayed by DEX-treated animals. The essential role of Bax in mediating the apoptotic actions of DEX was demonstrated by the fact that this GR agonist did not lead to apoptosis in bax Ϫ/Ϫ mice. Collectively, the above results are consistent with the proapoptotic nature of Bax (11, 3, 33, 51) and indicate that the expression of this molecule can be regulated by CS in the central nervous system. In addition, the Bax response (which correlates with the ultimate decision of a cell to die or not) after a particular hormonal manipulation seems to be critically dependent on the age of the subject insofar that the availability of MR and GR varies with age (5).
When CORT was administered at a dose to preferentially activate MR, the hippocampi of old, but not young, rats showed an increase in the relative number of bcl-x L mRNA transcripts. The changes in the older animals were accompanied by a reduced incidence of apoptosis after CORT treatment, thus conforming to the existing view of MR agonists as promoters of neuronal survival (7, 9, 50) . However, an unexpected finding was that the number of bcl-x L transcripts was reduced by the GR agonist DEX in the younger animals only. In light of our present (Fig. 2 ) and earlier observations (3), demonstrating that older subjects are more susceptible to the apoptosis-inducing actions of DEX, the latter finding indicates that the absolute levels of bcl-x L expression do not correlate directly with the degree of apoptosis induced by this particular stimulus. Later we consider the importance of the relative levels of apoptotic vs. antiapoptotic molecules within the cell that may provide a plausible explanation for this apparent discrepancy. At this point, it is pertinent to note, however, that aged animals show significant reductions in basal CS secretion and MR and GR abundance (3, 5) ; these alterations may contribute to the present observations on age-related differences in bcl-x L expression after treatment with MR and GR agonists. An interesting feature of our results is that they show that aged subjects have the potential to respond to neuroprotective (MR agonists) as well as neurodegenerative (GR agonists) stimuli with increases in the production of antiapoptotic molecules, and it is highly plausible that older animals are hypersensitive to MR agonist treatment. The fact that the neurons of aged rats are more susceptible to death after GR stimulation suggests that the 'defensive response' is nevertheless inadequate to counteract other death-precipitating factors.
The neuroprotective role of Bcl-2 in the adult hippocampus is best illustrated by the findings that 1) ischemia results in the induction of the bcl-2 gene in neurons that survive the hypoxic insult (CA3 pyramidal and dentate granular cells, cf. CA4 pyramidal cells that eventually die; see refs 24, 47, 55, 56) , and 2) certain areas of the adult brain, including the dentate gyrus, respond to traumatic injury with increases in bcl-2 gene transcription and translation (57) . A 'defensive' role for this protein is also suggested by the observation that Bcl-2 levels are increased in the basal ganglia of patients with Parkinson's disease or incidental Lewy body disease (58) . In the present study, bcl-2 gene expression was reduced in young animals and increased in old animals after treatment with an MR-activating dose of CORT. However, both age groups responded to the GR agonist DEX with suppressed expression of the bcl-2 gene. It deserves mention that a parallelism between changes in bcl-2 expression and cell survival (CORT) or death (DEX) was evident (cf. Fig. 2 and  4) . The apparently greater inducibility of bcl-2 in older rats than in younger ones may be related to the previously mentioned differences in basal CORT levels in the two age groups, i.e., the preexisting corticosteroid milieu may exert an important influence on the regulation of the bcl-2 gene.
Age and CS effects on neuronal apoptosis in the context of the balance between expression of proand antiapoptotic molecules
Although the present experiments revealed a clear correlation between the extent of apoptosis and expression of the proapoptotic gene bax, such a simple relationship was not discernible for the antiapoptotic molecules bcl-x L and bcl-2. Although there is evidence showing that members of the Bcl-2 family can also regulate apoptosis independently of interactions with each other (12, 59) , a 'rheostat model' has also been proposed. According to this model, the competitive dimerization between selective pairs of pro-and antiapoptotic molecules is a major determinant of whether a cell will ultimately survive or die, i.e., death will not ensue if sufficient amounts of repressor proteins are available to neutralize the death-inducing proteins (11, 18) . This prompted us to reevaluate our data in terms of the ratio of expression of the death agonist bax to that of the death antagonists bcl-x L and bcl-2 (cf. ref 31) .
In the present experiments, treatment of either young or old rats with the MR agonist CORT led to reduced bax:bcl-x L and bax:bcl-2 expression ratios (Fig. 5) , findings that match the reduced incidence of apoptosis after this treatment (Fig. 2) and support our suggestion that MR agonists help maintain dentate gyrus cell survival by inhibiting Bax synthesis. Taking these ratios as a measure, the older animals proved to be slightly more sensitive to CORT than their younger counterparts, a fact that may be related to the relatively lower basal levels of CORT to which older animals are physiologically exposed (see above). On the other hand, in view of our present (see Fig. 2 ) and earlier (3) findings that younger rats are less sensitive to the apoptosis-promoting effects of the GR ligand DEX, it was interesting to find that DEX caused a relatively greater increase in the ratio of bax:bcl-x L expression in the younger vs. older animals and that this treatment caused similar relative increases in the ratio of bax to bcl-2 gene expression in both age groups.
How are cell death/survival signals evoked by the activation of GR/MR transduced to regulatory molecules of the cell death machinery?
The results reported here provide the first analysis of how members of the bcl-2 gene family may mediate CS effects on neuronal survival and death in the dentate gyrus. The proteins encoded by the bcl-2 gene family are associated with either mitochondrial or nuclear membranes, and their effects include changes in the plasma membrane, redox potentials, protease activities, distribution of intracellular ions, and mitochondrial permeability transition phenomena; free radical generation has been implicated to underlie all these processes (13, 16, 60, 61) . We recently found DEX-induced apoptosis in the dentate gyrus to involve the generation of nitric oxide and possibly other reactive oxygen species (M. G. Canteros and O. F. X. Almeida, unpublished observations). However, the mechanisms by which changes in the CS status regulate bax, bcl-x L , and bcl-2 remain unknown. Since a GenBank database search failed to reveal potential MR and GR responsive elements in the published sequences of any of these genes, it is likely that the observed effects on their expression are indirect. A very likely candidate for mediation between CS receptors and Bcl-2 family members is the tumor suppressor protein p53. There are reports of interactions between GR and p53 (34, 62, 63) , a strong inducer of the death promoter bax (36, 37, 64, 65) while at the same time being a repressor of bcl-2 (36, 37) . Our present data indicating that hippocampal levels of p53 (including its phosphorylated forms) can be up-regulated by GR agonist treatment therefore support a role for this molecule in CS-mediated apoptosis.
In addition to p53, interactions between GR and a number of other transcription factors such as nuclear factor B and activator protein 1, which themselves show complex interactions, have been reported (66 -68) . All of these transcription factors have been implicated in cellular death and survival processes, depending on their ability to influence the transcription of death inducer or repressor genes (36, 37, 69) . Another indirect mechanism whereby CS may interact with Bcl-2 family members could involve the protein Bag-1; Bag-1 binds to Bcl-2 to promote cell survival, and since Bag-1 is negatively regulated by DEX (70, 71) , this mechanism could conceivably predispose a cell to apoptosis. Last, the number of possible permutations (CS ϫ transcription or other factors ϫ apoptotic genes) increase vastly in light of evidence suggesting that MR and GR may heterodimerize (72) .
Physiological and therapeutic significance
The data presented in this and our previous study (3) clearly show dichotomous effects of MR and GR activation on dentate cell survival. The effect of GR-induced neuronal apoptosis on brain function can conceivably be of considerable importance, given that the organism is frequently exposed to GR-activating levels of CS on both an intermittent (e.g., during stress) and cyclic (during the diurnal rise in adrenocortical activity) basis. Indeed, hippocampal neuronal loss is still thought to lead to hypersecretion of CS, which in turn has been causally related to disorders of mood and cognition (see refs 1, 4, 5, 73, 74) . These untoward effects on brain function are exaggerated in aging subjects, which also frequently show endocrine maladaptations to stress (1, 73) . However, the precise physiological significance of GR-mediated neuronal death remains unclear. Although previous studies have reported that stress leads to hippocampal cell death in rodents and primates (75) , recent stereological analyses show that chronic unpredictable stress does not reduce total cell numbers in either Ammon's horn or dentate gyrus (8) . One interesting line that emerges from this and our previous studies (3, 5; Wistar rats used in all studies) is that basal (MR-selective) levels of CS decline with increasing age. This alteration in adrenal activity may be a critical factor in rendering aged subjects more susceptible to the neurodegenerative processes that follow GR stimulation. Since our experiments show that aged animals can respond to MR-selective doses of CORT with increased production of antiapoptotic molecules, additional studies should be aimed at examining the extent to which therapeutic correction of MR ligand deficiency may lead to a reduction of age-related hippocampal cell loss and the mood and cognitive impairments associated with this phenomenon.
CONCLUSIONS
This work suggests that 1) GR activation results in a stimulation of Bax synthesis that leads to apoptosis in the dentate granule cell population, 2) the increased vulnerability of aged subjects to GR activation is a function of their impaired ability to up-regulate Bcl-x L , rather than Bcl-2, levels, and 3) supplementation of endogenous MR ligand levels may ameliorate age-dependent GR-mediated dentate cell loss. Further, we conclude that the balance between inducer and repressor proteins is a critical determinant of cell fate; in the dentate gyrus, this ratio depends on the degree of occupancy of MR or GR.
